AlphaYouVH
Schedule 13G filing
Venrock Healthcare Capital Partners III, L.P. disclosed a 5.6% stake in X4 Pharmaceuticals, Inc (XFOR)
Venrock Healthcare Capital Partners III, L.P. reported owning 5.6% of X4 Pharmaceuticals, Inc (XFOR) (5,555,047 shares) in a Schedule 13G filed Sep 22, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 22, 2026
- Source
- Schedule 13G
More XFOR insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.